New drug PRX019 takes first step: safety check in healthy people
NCT ID NCT06699680
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested a new drug, PRX019, in 50 healthy adults to see if it is safe and how the body handles it. Participants received either the drug or a placebo, and researchers monitored for side effects and measured drug levels in the blood. Since this is a first-in-human study, the main goal is gathering safety information, not treating any illness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PRX019
- What could go wrong
- This is a very early, first-in-human study with only 50 healthy participants. It is designed to check safety, not to treat any disease, so there is no guarantee the drug will work for any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Local Institution
Los Alamitos, California, 90720, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new experimental pill be safely given to people?
- Can a new injectable drug safely tackle weight? an early trial seeks answers
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Scientists map brain changes during Hour-Long DMT experience
- First human trial launches for experimental drug BY002
- New drug BW-50218 put to first safety test in healthy chinese volunteers